Obesity and Response to Advanced Therapies in Rheumatoid Arthritis.
Joshua F BakerGeorge ReedDilli Ram PoudelLeslie R HarroldJoel M KremerPublished in: Arthritis care & research (2022)
This study observed lower response rates among obese and underweight patients and no evidence of a superior effect of non-TNFi therapy over TNFi therapy in particular BMI categories.
Keyphrases
- rheumatoid arthritis
- metabolic syndrome
- weight loss
- end stage renal disease
- type diabetes
- ejection fraction
- newly diagnosed
- insulin resistance
- weight gain
- body mass index
- chronic kidney disease
- prognostic factors
- disease activity
- physical activity
- systemic lupus erythematosus
- mesenchymal stem cells
- cell therapy
- skeletal muscle
- patient reported
- replacement therapy